As of March 2025, the FDA considers the semaglutide shortage resolved
Meanwhile, GLP-1(3236) inhibited HG-induced excessive mitochondrial fission and mitochondrial stress
Here, we used the US Department of Veterans Affairs databases to build a cohort of people with diabetes who initiated GLP-1RA ( n = 215,970) and compared them to those who initiated sulfonylureas ( n = 159,465), dipeptidyl peptidase 4 (DPP4) inhibitors ( n = 117,989) or sodiumglucose cotransporter-2 (SGLT2) inhibitors ( n = 258,614), a control group composed of an equal proportion of individuals initiating sulfonylureas, DPP4 inhibitors and SGLT2 inhibitors ( n = 536,068), and a control group of 1,203,097 individuals who continued use of non-GLP-1RA antihyperglycemics (usual care)
Here are the key advantages: 1
Express Scripts also announced updates recently to another of its GLP-1 solutions, EncircleRx, which has more than 9 million enrolled patients and has saved health plans $200 million since 2024
Potential effects include: Improved cellular repair Reduced age-related decline Enhanced resilience to stress Better recovery capacity Longevity and Lifespan Research Animal studies have reported: Increased lifespan Improved health span Reduced age-related pathology Researchers continue to investigate whether similar effects may occur in humans